Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery
JS Kim, MI Liang, EN Prendergast… - International Journal of …, 2019 - ijgc.bmj.com
Objectives To compare clinical outcomes for stage IIIC and IV ovarian cancer patients
receiving neoadjuvant chemotherapy and interval cytoreductive surgery followed by up to …
receiving neoadjuvant chemotherapy and interval cytoreductive surgery followed by up to …